• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾眼癌发病率:18年回顾

Incidence of eye cancer in Taiwan: an 18-year review.

作者信息

Cheng C-Y, Hsu W-M

机构信息

Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

Eye (Lond). 2004 Feb;18(2):152-8. doi: 10.1038/sj.eye.6700619.

DOI:10.1038/sj.eye.6700619
PMID:14762407
Abstract

PURPOSE

To describe the incidence and histologic patterns of eye cancers in Chinese in Taiwan.

METHODS

Beginning in 1979, cases of cancer in Taiwan were reported to the Taiwan National Cancer Registry. Information on all Chinese patients diagnosed with eye malignancies under the International Classification of Disease, Ninth Revision, site 190, was retrieved for analysis from the data bank of the Taiwan National Cancer Registry.

RESULTS

In all, 733 cases with primary eye cancers were identified from 1979 to 1996, an 18-year period. The average annual age-standardized incidence of eye cancers was 2.46 per million population (2.57 for male and 2.33 for female). For cases less than 15 years of age, the most common eye malignancy was retinoblastoma (86.0%), followed by rhabdomyosarcoma (3.9%) and lymphoma (2.8%). For cases 15 years of age or older, the most common eye malignancy was melanoma (28.6%), followed by squamous cell sarcoma (21.0%) and lymphoma (20.8%).

CONCLUSIONS

The time trends of the incidence of eye cancers were relatively stable over the 18-year period in Taiwan. Retinobalstoma, melanoma, and lymphoma were the three most common eye cancers in this Chinese population.

摘要

目的

描述台湾地区中国人眼部癌症的发病率及组织学模式。

方法

自1979年起,台湾地区的癌症病例被报告至台湾地区癌症登记处。从台湾地区癌症登记处数据库中检索出所有根据国际疾病分类第九版第190位编码诊断为眼部恶性肿瘤的中国患者信息进行分析。

结果

在1979年至1996年这18年期间,共识别出733例原发性眼部癌症病例。眼部癌症的平均年龄标准化年发病率为每百万人口2.46例(男性为2.57例,女性为2.33例)。对于15岁以下的病例,最常见的眼部恶性肿瘤是视网膜母细胞瘤(86.0%),其次是横纹肌肉瘤(3.9%)和淋巴瘤(2.8%)。对于15岁及以上的病例,最常见的眼部恶性肿瘤是黑色素瘤(28.6%),其次是鳞状细胞肉瘤(21.0%)和淋巴瘤(20.8%)。

结论

在台湾地区,眼部癌症发病率的时间趋势在这18年期间相对稳定。视网膜母细胞瘤、黑色素瘤和淋巴瘤是该中国人群中最常见的三种眼部癌症。

相似文献

1
Incidence of eye cancer in Taiwan: an 18-year review.台湾眼癌发病率:18年回顾
Eye (Lond). 2004 Feb;18(2):152-8. doi: 10.1038/sj.eye.6700619.
2
Incidence of eyelid cancers in Taiwan: a 21-year review.台湾眼睑癌发病率:21年回顾。
Ophthalmology. 2006 Nov;113(11):2101-7. doi: 10.1016/j.ophtha.2006.06.001. Epub 2006 Sep 7.
3
Primary eye malignancy in Papua New Guinea.巴布亚新几内亚的原发性眼恶性肿瘤。
P N G Med J. 1975 Jun;18(2):83-6.
4
Incidence of retinoblastoma in the USA: 1975-2004.美国视网膜母细胞瘤的发病率:1975 - 2004年。
Br J Ophthalmol. 2009 Jan;93(1):21-3. doi: 10.1136/bjo.2008.138750. Epub 2008 Jul 11.
5
Retinoblastoma in Taiwan: incidence and survival characteristics from 1979 to 2003.台湾的视网膜母细胞瘤:1979 年至 2003 年的发病和生存特征。
Eye (Lond). 2010 Feb;24(2):318-22. doi: 10.1038/eye.2009.80. Epub 2009 Apr 17.
6
[Malignant tumors of the eye and adnexa in Congo-Kinshasa].[刚果民主共和国金沙萨地区眼及附属器恶性肿瘤]
J Fr Ophtalmol. 2000 Apr;23(4):327-32.
7
Time trends and characteristics of childhood cancer among children age 0-14 in Shanghai.上海0至14岁儿童癌症的时间趋势及特征
Pediatr Blood Cancer. 2009 Jul;53(1):13-6. doi: 10.1002/pbc.21939.
8
Trends in the incidence of oral cancer in Nova Scotia from 1983 to 1997.1983年至1997年新斯科舍省口腔癌发病率的趋势。
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Feb;95(2):205-12. doi: 10.1067/moe.2003.49.
9
Primary gastrointestinal cancers in the Western Region of Saudi Arabia. Is the pattern changing?沙特阿拉伯西部地区的原发性胃肠道癌症。模式正在改变吗?
Saudi Med J. 2000 Aug;21(8):730-4.
10
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.视网膜母细胞瘤幸存者发生二次恶性肿瘤的风险:超过40年的随访
J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9.

引用本文的文献

1
Development and evaluation of a quality-of-life questionnaire for patients with orbital malignant tumours.眼眶恶性肿瘤患者生活质量问卷的研制与评价
BMJ Open Ophthalmol. 2025 Jun 26;10(1):e001842. doi: 10.1136/bmjophth-2024-001842.
2
A 39-Year Nationwide Study of Uveal Melanoma in Taiwan.一项对台湾葡萄膜黑色素瘤长达39年的全国性研究。
Cancer Med. 2025 Apr;14(8):e70754. doi: 10.1002/cam4.70754.
3
The Epidemiology of Eye Cancer, Eyelid Cancer, and Ophthalmic Lymphoma in a Chinese Population in Hong Kong: A Population-Based Registry Study 2005-2018.
香港中国人群眼癌、眼睑癌和眼部淋巴瘤的流行病学:一项基于人群的2005 - 2018年登记研究
Invest Ophthalmol Vis Sci. 2025 Mar 3;66(3):15. doi: 10.1167/iovs.66.3.15.
4
Global incidence and trends of ocular cancer: A bibliometric analysis.眼癌的全球发病率及趋势:一项文献计量分析。
Adv Ophthalmol Pract Res. 2024 Oct 28;5(1):22-31. doi: 10.1016/j.aopr.2024.10.004. eCollection 2025 Feb-Mar.
5
In-vitro Cytotoxicity Investigations for Phytoconstituents of Saudi Medicinal Plants With Putative Ocular Effects.沙特药用植物植物成分的体外细胞毒性研究与潜在的眼部效应。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241256649. doi: 10.1177/15347354241256649.
6
Predictive Value of the International Classification of Diseases, 9th Revision Codes for Identifying Ocular Oncology Diagnoses.用于识别眼部肿瘤诊断的《国际疾病分类》第九版编码的预测价值
Ocul Oncol Pathol. 2023 Dec;9(5-6):158-165. doi: 10.1159/000534688. Epub 2023 Oct 26.
7
A Retrospective Study of Ocular Cancer in Saudi Arabia: 25-Year Analysis.沙特阿拉伯眼部癌症的回顾性研究:25年分析
Clin Ophthalmol. 2023 Oct 19;17:3103-3111. doi: 10.2147/OPTH.S433118. eCollection 2023.
8
Presentation and Management of Orbito-Ocular Malignancies in a Tertiary Institution in Southwest Nigeria.尼日利亚西南部一家三级医疗机构眼眶-眼部恶性肿瘤的临床表现与管理
J West Afr Coll Surg. 2023 Jan-Mar;13(1):1-5. doi: 10.4103/jwas.jwas_37_21. Epub 2023 Jan 18.
9
A joinpoint and age-period-cohort analysis of ocular cancer secular trends in Iran from 2004 to 2016.伊朗 2004 年至 2016 年眼部癌症的时间-时期-队列分析
Sci Rep. 2023 Jan 19;13(1):1074. doi: 10.1038/s41598-022-26349-x.
10
Clinical and Multimodal Imaging Features of Choroidal Nevi in the Korean Population.韩国人群脉络膜痣的临床及多模态影像学特征
J Clin Med. 2022 Nov 10;11(22):6666. doi: 10.3390/jcm11226666.